Summary A computerised self-assessment instrument was used to capture data on the distress caused by symptoms in 110 patients treated with radical radiotherapy. Patients selected symptoms from a list of 34 problems and then quantified the distress associated with each problem using a linear Analogue self assessment (LASA)-type scale. The test instrument was feasible: 90% of assessments were completed in under 14 min. There was a significant increase in tiredness and significant decrease in anxiety and worries about the family, during treatment. Menopausal symptoms and post-surgical problems were important causes of distress in the patients with breast cancer. When the area under the curve method was used to quantify distress in the patients with breast cancer, difficulty concentrating, pain and sleep disturbances emerged as significantly troublesome problems. Computerised self-assessment may have a useful role in quantifying the distress caused by treatment with radiotherapy.
Patients treated with radiotherapy have physical and psychological symptoms related both to the underlying disease and to the treatment. The distress caused by these symptoms can only be assessed adequately by the patients themselves (Slevin et al., 1988) . Inability to measure accurately and feasibly the symptomatic distress experienced by patients undergoing treatment with radiotherapy has, to an extent, hindered the rational scientific development of clinical radiotherapy. Factors influencing tumour control have been carefully analysed, but the price paid for that control, in terms of subjective distress, has largely been ignored. Prescribing practices vary widely (Priestman et al., 1989) and largely reflect previous training and/or institutional dogma (Maher, 1991) . Insufficient There are no standard instruments that address the specific concerns of patients during treatment with radiotherapy. There is an abundant literature on the assessment of 'quality of life' (Aaronson et al., 1993; Ganz et al., 1992; Selby et al., 1984; Olschewski et al., 1994) , but these instruments do not deal in detail with the particular symptoms that radiation treatment might itself produce. The tendency has been to concentrate on collapsed global indices. Radiotherapy causes quite specific symptoms, distress from which will probably impinge upon overall quality of life, but which will only be one aspect of a much broader and more complex domain. Collapsed indices are of little help in these circumstances. In order to improve standards, we need to be able to focus on the distress caused by specific problems in patients undergoing a course of radiotherapy treatment. In the absence of any standard instrument we have had to design our own test instrument.
In a previous study (Munro et al., 1989) (Zigmund and Snaith, 1983 Area under the curve (AUC) measurements could be obtained for each symptom for each individual patient. The calculation was performed according to the method described by Matthews et al. (1990) . The area under the curve for symptom score plotted against time was estimated as the sum of the measurements:
where t2 -t1 is the interval between the measurements and y, and Y2 are the symptom scores at the two time points.
Problems with the scheduling of interviews meant that complete data sets were not available for all patients. The problem of missing data was handled in three different ways:
(1) only complete data sets were analysed;
(2) zero was substituted for all missing values; (3) missing values were imputed using linear regression.
Correlation between the various components of the instrument has been assessed using Kendall's tau. The changes in responses over time have been assessed using the Wilcoxon matched-pairs signed-ranks test as well as the nonparametric test for trend described by Cuzick (1985) .
Results
A total of 110 patients were eligible for the study: there were 72 patients with breast cancer, average age 53 years (range 31-74 years); there were 24 patients with lung cancer, average age 71 years (range 46-81 years); there were 14 patients with head and neck cancer, average age 63 years (range 32-82 years). Feasibility All patients were able to complete the computerised questionnaire. There were no problems with non-compliance or technical malfunction. The average duration of each assessment was 10.0 min (95% CI 7.8-12.2), the median Measuring distress from radical radiotherapy r_ AJ Munro and S Polter 642 duration was 7.3 min and 90% of assessments were completed in under 14 min. There was evidence of a possible learning effect: the average duration of first interviews was 12.0 min (95% CI 10.0-14.), whereas the mean duration of the fourth interviews was 7.2 min (95% CI 6.6-7.7). The Pvalue for this difference is 0.0001 (z = 6.67) using the Wilcoxon signed-ranks matched-pairs test. It took an average of 2.3 min (95% CI 2.2-2.4) to administer the Hospital Anxiety and Depression scale in its computerised form; 90% of the HAD assessments were completed in less than 6.5 min.
Comparison between components of the computerised questionnaire and standard measures The correlation matrix in Table II shows values for Kendall's tau and P-values for those elements of the test instrument for which standard tests were available. The data come from the initial assessments on all 110 patients in the study. The reasonable correlation for appropriate comparisons (pain, the separate LASA scale for pain and the PPI) and, conversely, the poor correlations for inappropriate comparisons (for example, depression and the PPI) suggests that the components of the test instrument have both criterion validity and discriminant validity (Nunnally, 1978) .
Core questions (all 110 patients) The following 13 symptoms were selected by less than 30% of patients; sickness, weight loss, constipation, hoarseness, inconvenience of attending for treatment, not enough information about disease and its treatment, inadequate support, unable to care for self, difficulty swallowing, vomiting, pain on swallowing, decreased appetite, headache. They will therefore not be analysed in detail in this section. The data scores and counts for the 14 most frequently mentioned of the core symptoms are presented in Figure 1 . At the start of treatment 55% of patients selected tiredness as a symptom; by the end of treatment the figure was 71%. Anxiety seemed to diminish as a problem: 62% of patients mentioned anxiety at the beginning of treatment, but by the end of treatment only 42% selected anxiety from the list of problems. The data show a disparity in the relative ranking of symptoms according to whether the symptoms are ranked according to frequency or whether the ranking is by mean score for each problem. Frequent symptoms do not necessarily cause the most distress: the data on indigestion illustrate this point. Over 35% of patients complained of indigestion, but the mean score for indigestion was 1.96 and it ranked only 11th in terms of the distress it apparently caused. Our primary aim was to estimate distress rather than simply enumerate problems and the rest of the analysis is therefore based on the scoring, rather than the counting, of symptoms and problems.
Inspection of the data in Figure 1 Figure 2 shows the data for all symptoms which, on any occasion, had an average score >2 for each group of patients. The data are shown for the initial assessment (week 0), the end of treatment (week 3) and the first follow-up visit (week 7). There were too few patients with lung cancer or cancer of the head and neck for meaningful statistical anlaysis.
The data from the patients with breast cancer showed significant changes over time during the study period. Tiredness significantly increased between the start of treatment for breast cancer and the completion of radiotherapy (P=0.009, Wilcoxon). It then decreased so that by the first follow-up visit there was no significant difference from the pretreatment baseline (P= 0.9). There were no statistically significant changes during the first 2 weeks of treatment, but when the second week was compared with the third week there was a significant increase in the scores for tiredness (P=0.007, Wilcoxon). The sequential mean scores and 95% confidence intervals were: week 0, 3.9 (2.9-4.9); week 1, 4.77 (3.6-5.9); week 2, 5.25 (4.2-6.3); week 3, 6.85 (5.62-8.1); week 7, 4.2 (2.9-5.5). Other, more obviously direct, effects of radiotherapy followed a similar pattern: distress at not being able to wash properly increased between week 0 and week 3 (P = 0.016) then decreased between week 3 and week 7 (P=0.004). Similarly, changes in the skin of the breast increased during treatment (week 0 vs week 3, P=0.0003) then appeared to decrease (week 0 vs week 7, P= 0.06). Similar, but statistically non-significant, patterns were seen for heaviness of the treated breast and itching of the treated skin. particular symptoms. Difficulty concentrating, pain and sleep disturbances emerge as significant causes of distress in these patients when duration, as well as intensity, is taken into account.
Discussion
The use of computerised self-assessment to sort and score symptoms is clearly feasible. With 90% of assessments completed in less than 15 min, we have an instrument that could be used in routine clinical assessment for patients treated with radiotherapy. There is always the worry, in a project of this type, that the combination of technology and the intrusion into potentially sensitive areas might alienate patients, who might then either refuse to complete the assessments or press buttons at random in order to conclude the whole unpleasant business as speedily as possible. Our results suggest that this is not the case. Compliance was not a problem. The different, and appropriate, patterns of symptomatic distress in the three groups of patients suggest that the patients' responses were not produced at random and were a reasonable guide to what they were experiencing. Capturing the data was not a problem; the interpretation of the data, teasing out its true meaning, is much less straightforward.
The data from patients with lung cancer and cancers of the head and neck are too limited to permit any detailed conclusions to be drawn. Their main usefulness is to demonstrate that the patterns of response elicited are in accordance with prior expectation.
The data, from all 110 patients, on core symptoms confirm previous observations (Smets, 1993; Lamszus et al., 1994; Greenberg et al. (1992) have described a pattern of an initial decrease, followed by an increase, in tiredness during radiotherapy. We were unable to confirm this observation: our data show a steady increase during treatment, with the major impact being during the final week of treatment.
Simply asking patients whether they feel tired is a relatively crude measure. More precise measurements would undoubtedly be possible with a more specialised instrument such as the Multidimensional Fatigue Inventory (Smets et al., 1995) . Unfortunately, although the frequency and severity of tiredness as a symptom in irradiated patients has been well described, little specific treatment seems to be available. Patients should at least be warned what to expect and advised to pace their lives accordingly (Graydon et al., 1995) .
The patients with breast cancer had a significant number of physical problems directly related to their surgery and radiotherapy. Numbness of the axilla and inner arm was a major problem. It improved steadily during the period of the study but, even a month after the finish of radiotherapy, 2-3 months after surgery, was still a significant concern. Pain and heaviness in the treated breast were also troublesome. The impact of these problems was more clearly demonstrated using the AUC measurements.
Patients were allowed to wash during and after treatment, provided they did not use soap or deodorant and provided they did not rub out their skin marks. In spite of this relatively, but insufficiently, liberal policy, the inability to have a decent bath was clearly upsetting. The time course of itching in the treated skin was in accordance with expectation -maximal during the last week of treatment and settling thereafter. Adjuvant treatment caused significant upset. Hot flushes and increased sweating were consistent and distresssing problems.
The rank order of symptoms in terms of the distress caused depended upon the timing of the assessment. Feeling anxious and numbness of the axilla and arm were the dominant problems at the start of the treatment; by the end of treatment tiredness and numbness predominated; by the first follow-up visit tiredness, sweating and breast discomfort were the major causes of distress. The AUC data, by and large, confirm the visual impression given by the data in Figure 2 . Sleep difficulties fell in rank, and breast pain rose in rank, when AUC rather than mean score was used as the measure of distress. The interpretation and ranking of AUC measurements is not simple. Although such measurements are clearly useful in assessing the 'total' upset caused by an individual symptom during the period of observation (Matthews et al., 1990) there is, inevitably, oversimplification. A mildly troublesome, but persistent, symptom might well have an AUC value equal to that of a much more distressing problem of shorter duration. We are still left with the question of which is worse: a bang on the thumb with a hammer or persistent mild backache?
The information obtained from the patients with breast cancer suggests that there is a number of ways in which we might improve matters for patients treated with radiotherapy. Preliminary explanation and advice about tiredness are important. Patients might misinterpret tiredness related to treatment as being caused by progression of their cancer and, as a result, suffer unnecessary worry. We need to be more vigilant about analgesia, the use of non-steroidal antiinflammatory drugs might well improve some of the breast discomfort and heaviness that so obviously troubles patients. Washing instructions should be less restrictive-particularly since there is no evidence that normal washing makes skin reactions worse (Campbell and Illingworth, 1992) . The symptoms produced by the endocrine effects of adjuvant treatment may respond to low doses of progestagens (Loprinzi et al., 1994) -there is no reason to withhold such treatment from patients who are distressed by menopausal symptoms.
The feasibility of computerised self-assessment means that it is possible to consider using the technique in the routine evaluation of symptoms in patients treated with radiotherapy. The 10 to 15 min required for each evaluation could easily be accommodated within the normal waiting time for treatment. The technology used in our study was relatively primitive: a cheap laptop, a small black and white screen, no fancy graphics. Nevertheless, the patients found the system acceptable and easy to use. The use of colour, touchsensitive screens and more attractive graphics might make the approach even more acceptable for routine use. There are several possible roles for this type of assessment technique in clinical radiotherapy. In clinical studies comparing schedules of fractionation the treatment-related morbidity may be the main outcome of interest. Comparison of patients' subjective distress during treatment would be extremely useful adjunct to more traditional objective measures. Computerised self-assessment could play a similar role in comparisons and audit of supportive care regimensthe rapid acquisition of data that is both subjective and quantitative is crucial to such studies.
The assessment tool described here in no way attempts to measure overall quality of life (QOL). It is focused quite specifically on the problems and concerns associated with attendance for treatment with radiotherapy. Future studies should include comparison with a standard QOL measure, such as the EORTC questionnaire (Aaronson et al., 1993) . In this way we might be able to gauge more accurately the impact of radiotherapy-associated symptoms upon overall QOL. A further development would be to do as we have done for the HAD scale and to computerise the QOL instruments themselves.
